甲状腺癌患者第二原发恶性肿瘤的趋势:以色列一项基于人群的队列研究
该研究基于以色列国家癌症登记处数据,纳入1980-2009年诊断的甲状腺癌患者并随访至2011年12月31日,分析第二原发恶性肿瘤的发生率、风险及类型。结果显示男女第二原发恶性肿瘤的标准化发病比均显著升高,男性为1.23(CI 1.08-1.35),女性为1.19(CI 1.10-1.27),提示甲状腺癌患者为高风险人群。
要点
- 甲状腺癌患者第二原发恶性肿瘤总体发生率8.9%。
- 男性全部位第二原发恶性肿瘤SIR为1.23(CI 1.08-1.35)。
- 女性全部位第二原发恶性肿瘤SIR为1.19(CI 1.10-1.27)。
核心结论
- 以色列甲状腺癌患者第二原发恶性肿瘤的总体风险在两性中均显著高于一般人群。
- 甲状腺癌患者被确定为第二原发恶性肿瘤高风险群体,作者呼吁照护者应用特定的随访指南。
研究设计与样本
- 基于以色列国家癌症登记处的基于人群的队列研究。
- 纳入1980-2009年诊断的原发性甲状腺癌患者,随访第二原发恶性肿瘤发生至2011年12月31日。
- 共识别11,538例甲状腺癌患者。
- 排除107例重复病例后,分析1,032例第二原发恶性肿瘤患者的记录。
- 按初始甲状腺癌诊断时期(1980-1995年和1996-2009年)进行分层分析。
主要发现
- 第二原发恶性肿瘤发生率为8.9%。
- 男性全部位第二原发恶性肿瘤SIR为1.23(置信区间1.08-1.35)。
- 女性全部位第二原发恶性肿瘤SIR为1.19(置信区间1.10-1.27)。
- 男性中泌尿系统肿瘤和前列腺肿瘤的SIR显著升高。
- 女性中脑肿瘤、泌尿系统肿瘤、乳腺肿瘤和肺肿瘤的SIR显著升高。
临床怎么用
- 作者呼吁照护者应用特定的随访指南。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid cancer (TC) is the most common endocrine malignancy. TC patients have a good prognosis and a low disease-related mortality rate. Since such patients are often young, they may be at a higher risk for a second primary malignancy (SPM). This study sought to determine the incidence, risk, and types of SPM between 1980 and 2011, and to assess SPM trends over time among Israeli TC patients. METHODS: Data were derived from the Israel National Cancer Registry. Primary TC patients diagnosed during 1980-2009 were followed up for SPM incidence until December 31, 2011. Standardized incidence ratios (SIRs) of observed to expected SPM (based on the general population rates) were calculated using Poisson regression. Analyses were stratified by time period of initial TC diagnosis (1980-1995 and 1996-2009). RESULTS: A total of 11,538 TC patients were identified. After exclusion of 107 duplicate cases, records of 1032 patients with SPM were analyzed (an SPM incidence of 8.9%). SIRs for all-site SPMs were 1.23 [confidence interval 1.08-1.35] for males and 1.19 [confidence interval 1.10-1.27] for females. SIRs for tumors of the urinary system and prostate were significantly elevated in males, as were SIRs for tumors of the brain, urinary system, breast, and lung in females. Variables associated with increased risk of developing SPMs included a younger age at TC diagnosis, a shorter latency period, being born in Asia/Africa for both sexes, and being born in Israel for females. Compared with the general population, a subanalysis by TC diagnosis during 1980-1995 and 1996-2009 disclosed a higher SPM incidence for the latter time period in males and for both time periods, with a slightly higher SIR for the latter time period in females. CONCLUSIONS: The overall risk of SPM in Israeli TC patients was significantly greater for both sexes compared with the general population, thus identifying TC patients as a high-risk group and calling for caretakers to apply specific follow-up guidelines.
引用
- Izkhakov E, Barchana M, Liphshitz I, et al. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel. Thyroid. 2017. PMID: 28338430. doi:10.1089/thy.2016.0481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。